The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer

The MEK-ERK growth signaling pathway is important in human hepatocellular carcinoma (HCC). To evaluate the targeting of this pathway in HCC, we characterized a novel, orally-active MEK inhibitor, PD184161, using human HCC cells (HepG2, Hep3B, PLC, and SKHep) and in vivo human tumor xenografts. PD184...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Klein, Patrick J, Schmidt, C Max, Wiesenauer, Chad A, Choi, Jennifer N, Gage, Earl A, Yip-Schneider, Michele T, Wiebke, Eric A, Wang, Yufang, Omer, Charles, Sebolt-Leopold, Judith S
Формат: Artigo
Язык:Inglês
Опубликовано: Neoplasia Press Inc. 2006
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1601146/
https://ncbi.nlm.nih.gov/pubmed/16533420
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы